Navigation Links
MU researchers to collaborate on $20 million project
Date:9/7/2007

COLUMBIA, Mo. -- More than 10 million people in the United State have cancer, and more than half of them are women. For those who could still give birth, cancer treatments might signal the end of their fertility. Now, a new $20 million, 5-year program from the National Institutes of Health is creating a national team of scientists to investigate every aspect of fertility preservation for women with cancer. Part of that effort is being led by University of Missouri-Columbia researchers.

The national research team will investigate womens fertility preservation from all aspects including preservation of eggs, cancer treatments, current policies and practices, information available to women, and healthcare decision-making. The project, led by Teresa Woodruff, professor of obstetrics and gynecology at Northwestern University, includes more than 15 different institutions across the country.

MU researcher John Critser will receive approximately $1.25 million over five years to study cryopreservation methods of human eggs. The current methods are not efficient and there are many challenges in the cryopreservation process.

Its easy to freeze anything, but when biomaterial is frozen and thawed, the viability of the material is lost frequently, said Steve Mullen, a post-doctoral researcher in veterinary pathobiology. Most eggs in the ovaries are in the premature state, and in order to develop into mature and viable eggs, companion cells in the ovary are necessary. Therefore, freezing ovarian tissue, which is usually necessary for female fertility preservation, is very challenging because all of the different cell types must be preserved so that they can cooperate to mature the egg after the tissue is thawed.

Critser and Mullen, along with MU colleagues Danny Schust, associate professor of obstetrics, gynecology and womens health; James Benson, a graduate student in Department of Applied Mathematics; and Xu Han, a post-doctoral fellow in veterinary pathobiology, will collaborate with researchers from other institutions involved in the project.

The long term goal is to allow people to have children who otherwise might not be able to do so, said Critser, Gilbreath McLorn Professor of Comparative Medicine. We are working to help women stay fertile and this new NIH roadmap combining interdisciplinary groups to study a problem from all angles will be vital to solving this problem.

As we become better at curing patients of diseases that would have previously been invariably fatal, we also have a responsibility to maximize the opportunities that accompany survivorship, Schust said. Cancer survivors put child-bearing very high on their list of post-therapy lifetime goals. This study should help us to simultaneously meet our responsibilities as health care providers and satisfy these very vital patient needs.

As part of the project, each member institution will have a representative that sits on a Board of Governors overseeing the project. MUs representative will be William Crist, Hugh E. and Sarah D. Stephenson Dean of the School of Medicine.

Due to tremendous advances in medical research, millions of people who would have previously died of cancer now require care focused on improving their quality of life, Crist said. Preserving fertility for women has become an increasingly important aspect of cancer survivorship, and MU is proud to contribute to this national effort to enrich the lives of cancer survivors and their families.


'/>"/>
Contact: Christian Basi
BasiC@missouri.edu
573-882-4430
University of Missouri-Columbia
Source:Eurekalert

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
4. New Hair in 15 Days Could Now Be A Possibility Say Researchers
5. Researchers at Cornell University as been reported using research fund by false claims
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. Gene researchers make Malaria-resistant mosquito
9. Researchers developed world’s smallest toothbrus
10. Researchers discover receptor cells that can cause epilepsy
11. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: